Associated Papers
Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.
Smorodinsky-Atias K et al.
Cells, 2020
ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.
Goetz EM et al.
Cancer Research, 2014
Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2.
Butch ER et al.
The Journal of Biological Chemistry, 1996
Select a paper to view details